Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932074 · ClinicalTrials.gov registry record · Phase 1
A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
A Phase 1 study, sponsored by Kaken Pharmaceutical.
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT00932074 is a Phase 1 study that has completed, run by Kaken Pharmaceutical. The registered enrollment target is 58 participants.
The verdict
NCT00932074, a Phase 1 study, has completed, sponsored by Kaken Pharmaceutical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety, tolerability and efficacy of KP-413 topical ointment compared with vehicle ointment in treating adult subjects with atopic dermatitis (AD).
Interventions
- DRUG KP-413 Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00932074
The ClinicalTrials.gov registry entry for NCT00932074 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaken Pharmaceutical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KP-413 Ointment is the first listed.
NCT00932074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00932074 about?
NCT00932074 is a clinical study titled "A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)". The purpose of this study is to assess the safety, tolerability and efficacy of KP-413 topical ointment compared with vehicle ointment in treating adult subjects with atopic dermatitis (AD).
What is the current status of trial NCT00932074?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2009-07. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00932074?
The interventions under investigation include: KP-413 Ointment (DRUG).
Who is sponsoring clinical trial NCT00932074?
This trial is sponsored by Kaken Pharmaceutical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.